Consistent with these findings, whole blood expression of activation-related genes12—such as HLADRB1 and CD86—were significantly decreased, and expression of exhaustion-related genes13—such as PLAUR and RELB—were significantly increased in VEXAS patients compared to other groups (Supplementary Fig. 4C). The gene discussed is RELB; the disease is VEXAS syndrome.